Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1991
10/29/1991US5061788 Elicit immune response against merozoite stage of parasite
10/29/1991US5061641 Method for radiolabeling proteins
10/29/1991US5061626 Antigenic anarogues of platelet activating factor
10/29/1991US5061623 Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides
10/28/1991WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME
10/28/1991WO1991016928A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
10/28/1991WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991WO1991016819A1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein
10/28/1991CA2081479A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
10/28/1991CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof
10/28/1991CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same
10/25/1991WO1991016628A1 Purification, detection and methods of use of protease nexin-2
10/25/1991CA2079880A1 Purification, detection and methods of use of protease nexin-2
10/24/1991WO1991016345A1 Cyclic peptides and their use
10/24/1991DE4039747A1 Polysaccharide vaccine adjuvant contg. aminoalkyl oxy functional gps. - for vaccines readily administered, useful in human and veterinary medicine
10/24/1991CA2081312A1 Cyclic peptides and their use
10/23/1991EP0453216A2 The use of autologous promoters to express gene products in bordetella
10/23/1991EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
10/23/1991EP0453082A1 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
10/23/1991EP0453024A1 Actinobacillus pleuropneumoniae subunit vaccine
10/23/1991EP0452849A1 Anti-PP4 monoclonal antibodies, method for production and use thereof
10/23/1991EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins
10/23/1991EP0452319A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses
10/23/1991EP0452315A1 Method of treating myeloid leukemias
10/23/1991EP0172178B1 Method for cell culture
10/23/1991EP0170697B1 Toxin conjugates
10/23/1991CN1055541A Improved meninggococcal polysaccharide conjugate vaccine
10/22/1991US5059680 Method of isolating ca 125 antigen
10/22/1991US5059654 Affinity matrices of modified polysaccharide supports
10/22/1991US5059538 Recombinant plasmid inserted with herpes simplex virus gene
10/22/1991US5059537 Acellular vaccine
10/22/1991CA1291035C Shiga vaccine
10/20/1991CA2040770A1 Administration of monoclonal antibodies against respiratory viruses
10/19/1991WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
10/19/1991WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2080835A1 A 35kd tumor associated protein antigen and immune complex
10/19/1991CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation
10/19/1991CA2040722A1 Monoclonal antibodies against pp4, processes for the preparation thereof and the use thereof
10/17/1991WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
10/17/1991WO1991015587A1 Self-polymerising expression system based on modified potyvirus coat proteins
10/17/1991WO1991015586A1 Improvements relating to the detection of viruses
10/17/1991WO1991015572A1 Live vaccines
10/17/1991WO1991015571A1 Expression of heterologous protein in yeast
10/17/1991WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides
10/17/1991WO1991015238A1 Methods and compositions for vaccination against hiv
10/17/1991WO1991015237A1 Compositions and treatments for pneumonia in animals
10/17/1991WO1991015225A1 Multiple sclerosis t-cell receptor
10/17/1991WO1991015224A1 Inhibition of disease associated with immunodeficiency virus infection
10/17/1991WO1991015221A1 Inhibition of allograft and concordant xenograft rejection
10/17/1991WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
10/17/1991CA2078546A1 Methods and compositions for vaccination against hiv
10/17/1991CA2060318A1 Hydroxyapatite-antigen conjugates and methods for generating a poly-ig immune response
10/16/1991EP0451972A1 Utilization of enzymes
10/16/1991EP0451880A2 An ex vivo tissue perfusion composition and the use thereof
10/16/1991EP0451800A1 Binding of allergens to a solid phase
10/16/1991EP0451612A1 Anti-oncostatin M monoclonal antibodies
10/16/1991EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins
10/16/1991EP0451357A1 Pathogenesis factors of dermatophytes
10/16/1991EP0229810B1 Protection of proteins and the like
10/16/1991EP0193561B1 Monoclonal antibodies against metal chelates
10/15/1991US5057540 Saponin adjuvant
10/15/1991US5057503 Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
10/15/1991US5057426 Method for separating long-chain nucleic acids
10/15/1991US5057411 For identifying specific viruses
10/15/1991US5057314 Low molecular weight antiviral factors
10/15/1991CA1290713C Protein and production thereof
10/14/1991CA2080002A1 Composition for macrophage activation
10/14/1991CA2039958A1 Binding of allergens to a solid phase
10/09/1991EP0450936A1 Monoclonal antibody to avermectins
10/09/1991EP0450800A1 Utilization and delivery of enzymes
10/09/1991EP0450715A1 Immunogenic compounds, the process for their synthesis and their use in the preparation of antimalaria vaccines
10/09/1991EP0450598A2 Inhibitors of the advanced glycosylation of proteins and methods of use therefor
10/09/1991EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections
10/09/1991EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma
10/09/1991EP0450412A1 Heat-treated IgM antibody preparations
10/09/1991EP0449980A1 Sequential peptide and oligonucleotide synthesis using immunoaffinity techniques
10/09/1991EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom
10/09/1991CN1055116A Method for producting pharmaceutical composition containing il-4 as active ingredient
10/08/1991US5055562 Fluorocarbon chain-containing antigenic conjugates
10/08/1991US5055557 Ultrapurification of factor IX and other vitamin K-dependent proteins
10/08/1991US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material
10/08/1991US5055447 Administering transforming growth factor beta
10/08/1991US5055404 Monoclonal antibody specifically reactive to surface of human prostatic epithelial cells
10/08/1991US5055400 Cloning and expression of leukotoxin gene of pasteurella in suitable host microorganism
10/08/1991US5055391 Method and kit or detecting antibodies to antigens of human immunodeficiency virus type 2 (hiv-2)
10/08/1991US5055292 Vaccines for coccidiosis comprising live sporulated oocysts from strains of eimeria species
10/08/1991US5055289 Dual specificity against therapeutically active agent and against a disease related antigen
10/08/1991CA1290265C Monoclonal antibody specific for a pigmentation associated antigen
10/08/1991CA1290245C Methods for diagnosis and therapy of multiple sclerosis
10/07/1991WO1991015516A2 Hepatitis c virus epitopes
10/07/1991CA2038978A1 Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
10/06/1991CA2039541A1 Monoclonal antibodies to avermectins
10/05/1991WO1991015505A1 Purification of a pertussis outer membrane protein
10/05/1991CA2359307A1 Pertussis outer membrane protein
10/04/1991WO1991015574A1 Purified hcv and hcv proteins and peptides
10/04/1991WO1991015512A2 Hiv envelope polypeptides
10/04/1991CA2079677A1 Purified hcv and hcv proteins and peptides
10/04/1991CA2078545A1 Hiv envelope polypeptides
10/04/1991CA2039542A1 Inhibitors of the advanced glycosylation of proteins and methods of use therefor
10/04/1991CA2022523A1 Chemically modified cd4 peptide fragments having anti-retroviral properties
1 ... 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 ... 1823